Drug intelligence / Profile preview

Unifive

Development stage
Discontinued
Lead developer
Biological E
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Unifive is a liquid pentavalent vaccine developed to provide active immunity against five major childhood diseases: diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b (Hib). It is a combination of diphtheria and tetanus toxoids, inactivated whole-cell Bordetella pertussis, recombinant hepatitis B surface antigen (HBsAg), and purified capsular polysaccharide of Hib conjugated to a tetanus toxoid carrier. As a fully liquid formulation, it eliminates the need for reconstitution in the field, thereby reducing the risk of contamination and administration errors. Unifive is WHO-prequalified and is primarily utilized in national immunization programs across various developing nations to improve coverage and reduce the number of injections required for infants.

Brand names
Unifive
Other names
DTP-HepB-Hib vaccinePentavalent vaccine
02

Targets

HBsAg (Hepatitis B surface antigen)Diphtheria toxin

Beyond the preview

Go deeper on Unifive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unifive.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call